-transparent.png){kind=logo}
Alprazolam treatment was tapered in 17 panic patients at a rate of 10% of the starting dose every 3 days. Only four subjects completed withdrawal on schedule (4-5 weeks); four additional subjects discontinued treatment in 7-13 weeks. During withdrawal 15 patients had recurrent or increased panic attacks and nine had significant new withdrawal symptoms. Most common among the latter were malaise, weakness, insomnia, tachycardia, lightheadedness, and dizziness. None had seizures, psychosis, or significant neurological or EEG abnormalities. Results indicate that relapse and withdrawal are important considerations in the choice of alprazolam treatment for panic attacks.
Related Publications
A J Fyer, and
M R Liebowitz, and
J M Gorman, and
R Campeas, and
A Levin, and
S O Davies, and
D Goetz, and
D F Klein
January 1993,
Journal of psychiatric research,
A J Fyer, and
M R Liebowitz, and
J M Gorman, and
R Campeas, and
A Levin, and
S O Davies, and
D Goetz, and
D F Klein
October 1992,
Journal of clinical psychopharmacology,
A J Fyer, and
M R Liebowitz, and
J M Gorman, and
R Campeas, and
A Levin, and
S O Davies, and
D Goetz, and
D F Klein
July 1989,
The American journal of psychiatry,
A J Fyer, and
M R Liebowitz, and
J M Gorman, and
R Campeas, and
A Levin, and
S O Davies, and
D Goetz, and
D F Klein
August 1988,
The Journal of clinical psychiatry,
A J Fyer, and
M R Liebowitz, and
J M Gorman, and
R Campeas, and
A Levin, and
S O Davies, and
D Goetz, and
D F Klein
July 1987,
The Journal of clinical psychiatry,
A J Fyer, and
M R Liebowitz, and
J M Gorman, and
R Campeas, and
A Levin, and
S O Davies, and
D Goetz, and
D F Klein
June 1986,
The Journal of clinical psychiatry,
A J Fyer, and
M R Liebowitz, and
J M Gorman, and
R Campeas, and
A Levin, and
S O Davies, and
D Goetz, and
D F Klein
June 1994,
The American journal of psychiatry,
A J Fyer, and
M R Liebowitz, and
J M Gorman, and
R Campeas, and
A Levin, and
S O Davies, and
D Goetz, and
D F Klein
August 1995,
The American journal of psychiatry,
A J Fyer, and
M R Liebowitz, and
J M Gorman, and
R Campeas, and
A Levin, and
S O Davies, and
D Goetz, and
D F Klein
August 1994,
The American journal of psychiatry,
A J Fyer, and
M R Liebowitz, and
J M Gorman, and
R Campeas, and
A Levin, and
S O Davies, and
D Goetz, and
D F Klein
October 1984,
Texas medicine,
